SCHEMBL8108440

SCHEMBL8108440

CSC1N(CC(=O)NCc2ccccc2)C(=O)C1(C)C

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.49
POLB P06746 1/20 0.49
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
HTT P42858 3/20 0.48
LMNA P02545 3/20 0.45
KDM4E B2RXH2 1/20 0.45
USP2 O75604 1/20 0.44
HPGD P15428 1/20 0.44
GAA P10253 2/20 0.43
TSHR P16473 2/20 0.43
MEN1 O00255 1/20 0.43
THRB P10828 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8104215 0.79 SMN1; SMN2 (0.48) SMN1; SMN2POLBNPC1RAB9AHTT
SCHEMBL8102553 0.77 NPC1 (0.54) SMN1; SMN2POLBNPC1RAB9AHTT
SCHEMBL8102557 0.77 NPC1 (0.54) SMN1; SMN2POLBNPC1RAB9AHTT
SCHEMBL8094757 0.77 HTT (0.51) SMN1; SMN2POLBNPC1RAB9AHTT
SCHEMBL8094756 0.77 HTT (0.51) SMN1; SMN2POLBNPC1RAB9AHTT
SCHEMBL8102648 0.77 HTT (0.51) SMN1; SMN2POLBNPC1RAB9AHTT
SCHEMBL8102549 0.77 NPC1 (0.54) SMN1; SMN2POLBNPC1RAB9AHTT
SCHEMBL8102580 0.76 KMT2A (0.40) KMT2A
SCHEMBL8104181 0.68 HTT (0.50) SMN1; SMN2POLBNPC1RAB9AHTT
SCHEMBL8104235 0.68 HTT (0.50) SMN1; SMN2POLBNPC1RAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0788478-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-08-13 EP claimed
WO-1996013484-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1996-05-09 WO claimed
US-6071899-A Azetidinone derivatives for the treatment of atherosclerosis SMITHKLINE BEECHAM P.L.C. (GB) 2000-06-06 US disclosed